This is the first study to date investigating a measure of anisocytosis in relation to CBF in the AD trajectory and specifically examining the effect of APOE4 status by focusing on differences between carriers of at least one copy of APOE4 and non-carriers. Here, APOE is linked to Alzheimer disease.